top of page
color cloud.png

Bernard Lerer

Hadassah Medical Center, Hebrew University
Israel

Bernard Lerer is Professor of Psychiatry and Head of Hadassah BrainLabs (https://brainlabs.org.il/) at Hadassah – Hebrew University Medical Center in Jerusalem. He was trained at the University of Cape Town Medical School, Hadassah Medical Center and Herzog Hospital, Jerusalem and was a post-doctoral research fellow with Prof. Samuel Gershon at Lafayette Clinic, Wayne State University, Detroit. His main research interest is the neurochemical mechanisms of antidepressants, mood stabilizers and brain stimulation as a basis for novel drug development. Recently, he has established a comprehensive preclinical and translational program focused on the psychiatric applications of psychedelic drugs. He has 386 PubMed listed original scientific publications and has edited 4 books. He has received numerous awards, most recently the 2019 Lifetime Achievement Award of the International Society for Affective Disorders (ISAD). He was Founding Editor-in-Chief of the International Journal of Neuropsychopharmacology (1998-2008). Bernard Lerer holds several patents in psychopharmacology and pharmacogenetics and has mentored more than 100 PhD and MSc students and psychiatrist research trainees.

color cloud.png

Stay Up to Date

Never miss a deadline. Get the latest to your inbox. 

Thanks for subscribing!

About Psychedelic Medicine – Israel 2026

With the rediscovery of psychedelic drugs as potential treatments for psychiatric disorders, we may be on the verge of the next revolution. The potential impact of psychedelics is not limited to psychiatry. Fields such as neurology, palliative care, addiction and pain medicine are among the potential beneficiaries along with inflammatory and possibly autoimmune disorders. 

Conference Organizer
comtec_med.jpg
bottom of page